LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕
    21/09/2022
    21/09/2022

    EuropaBio sat down with new Member Freget Glaser & Associés, to learn more about investment and growth opportunities for European biotechnology

    Do you like it?
    Read more
    21/09/2022
    21/09/2022

    Freget Glaser & Associés joins EuropaBio: steering the innovation potential through a secure legal framework

    Do you like it?
    Read more
    19/09/2022
    19/09/2022

    Biotech SMEs are the heart of Europe’s healthcare ecosystem – hear their voice.

    Do you like it?
    Read more
    07/09/2022
    07/09/2022

    EuropaBio response to the public consultation on the proposal for a Regulation on substances of human origin (SoHO)

    Do you like it?
    Read more
    07/09/2022
    07/09/2022

    Factsheet – Increased regulatory efficiency; what we need for the next generation of medicine

    Do you like it?
    Read more
    07/09/2022
    07/09/2022

    Factsheet – European Health Data Space

    Do you like it?
    Read more
    07/09/2022
    07/09/2022

    Factsheet – A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare

    Do you like it?
    Read more
    27/07/2022
    27/07/2022

    EuropaBio position on the European Health Data Space proposal

    Do you like it?
    Read more
    18/07/2022
    18/07/2022

    EuropaBio Statement on the proposal for a Regulation on substances of human origin (SoHO)

    Do you like it?
    Read more
    27/06/2022
    27/06/2022

    Unlocking the Promise of Gene Therapy

    Do you like it?
    Read more
    20/06/2022
    20/06/2022

    Seizing opportunities for continued innovation, investment, and excellence in orphan medicines in Europe

    Do you like it?
    Read more
    25/05/2022
    25/05/2022

    European Week Against Cancer 2022 – Interview with Santiago Aguirre, Market Lead Europe Oncology, Sanofi

    Do you like it?
    Read more
    23/05/2022
    23/05/2022

    Jamie Wilkinson new Healthcare Biotechnology Director at EuropaBio

    Do you like it?
    Read more
    16/05/2022
    16/05/2022

    EuropaBio Statement on the Evaluation of the Cross-Border Healthcare Directive

    Do you like it?
    Read more
    12/05/2022
    12/05/2022

    A New European Innovation Agenda: biotechnology will help achieve a healthier, more sustainable, and autonomous Europe

    Do you like it?
    Read more
    08/03/2022
    08/03/2022

    EuropaBio National Associations Council Summit 2022: modernised regulation and legislation will deliver the potential of European biotechnology

    Do you like it?
    Read more
    28/02/2022
    28/02/2022

    EuropaBio Statement on Rare Disease Day

    Do you like it?
    Read more
    31/01/2022
    31/01/2022

    EuropaBio becomes a partner of a new European partnership for health

    Do you like it?
    Read more
    22/12/2021
    22/12/2021

    EuropaBio: Revision of the EU general pharmaceuticals legislation for a healthier tomorrow

    Do you like it?
    Read more
    15/12/2021
    15/12/2021

    EuropaBio sat down with new member MabDesign, to find out about its work with the French biopharmaceutical industry

    Do you like it?
    Read more
    Load more
    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.